Andrew McLeod
Optometrist · Boston, MANPI 1275735888
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,817 of the $5,933 with a category attached, or 64.3%. 18 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 28.5% of the total. Among optometrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $61.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$2K
- Biotissue Holdings Inc.$1K
- Bausch & Lomb Americas Inc.$383
- Johnson & Johnson Vision Care, Inc.$325
- Alcon$319
- Glaukos Corporation$295
- plus $1K from 12 others
Across 5 payments — averaging $560.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tarsus Pharmaceuticals, Inc.$3K
What the payments were for
- Consulting fees$97516%
- Speaking & faculty fees$3005%
- Travel & lodging$84114%
- Food & beverage$3,81764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 24 | $1,691 |
| Biotissue Holdings Inc. | 8 | $1,466 |
| Bausch & Lomb Americas Inc. | 14 | $383 |
| Johnson & Johnson Vision Care, Inc. | 6 | $325 |
| Alcon | 7 | $319 |
| Glaukos Corporation | 2 | $295 |
| Dompe US, Inc. | 6 | $272 |
| Oyster Point Pharma, Inc. | 4 | $243 |
| Coopervision Inc. | 6 | $216 |
| Sight Sciences, Inc. | 3 | $186 |
| Novartis | 5 | $184 |
| Rxsight Inc | 1 | $83 |
| Sun Pharmaceutical Industries Inc. | 2 | $78 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $69 |
| AbbVie | 2 | $54 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $31 |
| Lombart Brothers, Inc. | 1 | $21 |
| ABB Con-cise Optical Group LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$581
- Acuvue$243
- CE-marked KXLA system$186
- TearCare$142
- INFUSE$129
- Oxervate$118
- TYRVAYA$114
- Biofinity Contact Lens$113
- DAILIES$113
- iStent Infinite$109
How this compares
$5,933 in reported general payments places this provider in the 95th percentile of 1,084 optometrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $182 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Boston
- Donald KorbBoston$373K
- Jaclyn GarlichBoston$162K
- Kristen BrownBoston$87K
- Timothy BossieBoston$75K
- Xiaohong ZhouBoston$21K
- Jennifer LiaoBoston$16K
- Alexa CarusoBoston$10K
- Gary ChuBoston$10K
- Paul CangianoBoston$9K
- Shirley SalomonBoston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.